Haptoglobin and risk of myocardial infarction, stroke, and congestive heart failure in 342,125 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
Authors:
- Ingar HolmeIHIngar Holme
- Are H. AastveitAAAre H. Aastveit
- Niklas HammarNHNiklas Hammar
- Ingmar JungnerIJIngmar Jungner
- Göran WalldiusGWGöran Walldius
- 1 January 2009
- journal article
- Published by Taylor & Francis in Annals of Medicine
- Vol. 41 (7) , 522-532
Abstract
Few studies have analysed the importance of haptoglobin (Hp) as a risk factor for acute myocardial infarction (AMI), stroke, and heart failure (HF) in large healthy populations. We examined Hp as risk factor for AMI, stroke, and HF in the Apolipoprotein MOrtality RISk (AMORIS) Study and compared its predictive strength with that of total serum cholesterol (TC). Prospective study (11.8 years) of AMI, stroke, and HF through linkage with Swedish hospital discharge and mortality registers with measurements of Hp in 342,125 subjects. Hp is a significant risk factor of AMI, stroke, and HF. Relationships were stronger for men than women with regard to stroke and HF, but not AMI. Hp was almost as predictive as TC for AMI and about equally predictive of stroke with a stronger relationship to ischaemic than haemorrhagic stroke. A 4.2-fold increase in risk of AMI was observed comparing subjects in the joint lower quartiles of TC and Hp to those in the upper. For stroke, the risk increase was 2-fold, and 1.5-fold for HF. The inflammation marker Hp carried as much additional predictive information value on AMI and stroke as TC. Hp was also a risk factor of HF.Keywords
This publication has 30 references indexed in Scilit:
- C-Reactive Protein: Eighty Years from Discovery to Emergence as a Major Risk Marker for Cardiovascular DiseaseClinical Chemistry, 2009
- Haptoglobin, inflammation and diseaseTransactions of the Royal Society of Tropical Medicine and Hygiene, 2008
- Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow‐up periods in the Apolipoprotein MOrtality RISk study (AMORIS)Journal of Internal Medicine, 2008
- Stroke mortality and the apoB/apoA‐I ratio: results of the AMORIS prospective studyJournal of Internal Medicine, 2006
- Risk of Myocardial Infarction and Stroke in Smokers Is Related to Plasma Levels of Inflammation-Sensitive ProteinsArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Inflammation-Sensitive Plasma Proteins and Incidence of Myocardial Infarction in Men With Low Cardiovascular RiskArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Effects of Cholesterol and Inflammation-Sensitive Plasma Proteins on Incidence of Myocardial Infarction and Stroke in MenCirculation, 2002
- Inflammation and AtherosclerosisCirculation, 2002
- High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective studyThe Lancet, 2001
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999